A platform to analyze HIV treatment outcomes and prognosis
A secure analytics platform to study the prognosis of people with HIV in the USA, Canada and Europe and comparative effectiveness of treatment regimens: the Antiretroviral Therapy Cohort Collaboration
['FUNDING_R01'] · UNIVERSITY OF BRISTOL · NIH-11007409
This study is looking at how well different HIV treatments work for people living with HIV in the USA, Canada, and Europe, using a large set of data while keeping your information private, to help improve care for those aging with the condition.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF BRISTOL (nih funded) |
| Locations | 1 site (BRISTOL, UNITED KINGDOM) |
| Trial ID | NIH-11007409 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a secure analytics platform to study the prognosis of people living with HIV (PWH) in the USA, Canada, and Europe. By utilizing a large dataset from the Antiretroviral Therapy Cohort Collaboration, which includes data on approximately 250,000 individuals, the project aims to compare the effectiveness of various antiretroviral therapy regimens. The research will ensure participant privacy while allowing researchers to conduct meaningful analyses that can inform treatment strategies for aging populations with HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 21 and older who are living with HIV and receiving antiretroviral therapy.
Not a fit: Patients who are not living with HIV or those who are not receiving antiretroviral therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better health outcomes for people living with HIV.
How similar studies have performed: Previous research using large cohort collaborations has shown success in improving treatment outcomes for HIV, indicating that this approach is both tested and promising.
Where this research is happening
BRISTOL, UNITED KINGDOM
- UNIVERSITY OF BRISTOL — BRISTOL, UNITED KINGDOM (ACTIVE)
Researchers
- Principal investigator: STERNE, JONATHAN — UNIVERSITY OF BRISTOL
- Study coordinator: STERNE, JONATHAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus